Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

792 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Preventing Alcohol Withdrawal Syndrome With Oral Baclofen

NCT02052440

Alcohol Withdrawal Syndrome

TERMINATED PHASE3

Treatment of Alcohol Withdrawal in Hospital Patients

NCT00249366

Alcohol Withdrawal Syndrome

COMPLETED PHASE4

Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants

NCT05438641

Alcohol Withdrawal Syndrome

COMPLETED

Preventing Alcohol Withdrawal With Oral Baclofen

NCT01937364

Alcoholism Alcohol Withdrawal

TERMINATED PHASE2

Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention

NCT04572750

Taking Benzodiazepines for Any Reason for 3 Months Benzodiazepine Dependence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Withdrawal Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Benzodiazepine-resistant

those patients with either 1) a requirement of either 200 mg of diazepam (or diazepam equivalents) in 4 hrs; 2) \>40mg of diazepam (or diazepam equivalents) in 1 hr; or 3) an individual dose of 40 mg or greater of intravenous diazepam for control of agitation

Diazepam

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diazepam

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

either

1. a requirement of either 200 mg of diazepam (or diazepam equivalents) in 4 hrs;
2. \> 40mg of diazepam (or diazepam equivalents) in 1 hr; or
3. an individual dose of 40 mg or greater of intravenous diazepam for control of agitation